Press release
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Shareholder Notice: Deadline in Lawsuit on May 5, 2025
A Deadline is coming up on May 5, 2025 in the lawsuit for certain investors in Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI).
Investors who purchased shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) have certain options and there are strict and short deadlines running. Deadline: May 5, 2025. NASDAQ: MRVI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges on behalf of purchasers of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) common shares between August 7, 2024 and February 24, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 7, 2024 and February 24, 2025, the Defendants failed to disclose to investors that Maravai LifeSciences Holdings lacked adequate internal controls over financial reporting related to revenue recognition, that as a result, the Company inaccurately recognized revenue on certain transactions during fiscal 2024, that its goodwill was overstated, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Shareholder Notice: Deadline in Lawsuit on May 5, 2025 here
News-ID: 3982229 • Views: …
More Releases from Shareholders Foundation
Investors who hold shares of ESSA Pharma Inc. (NASDAQ: EPIX) Long Term should co …
An investigation was announced for long-term investors in shares of ESSA Pharma Inc. (NASDAQ: EPIX) concerning potential breaches of fiduciary duties by certain directors of ESSA Pharma Inc.
Investors who are current long term investors in ESSA Pharma Inc. (NASDAQ: EPIX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Zenas BioPharma, Inc. …
An investor, who purchased shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO), filed a lawsuit over alleged violations of Federal Securities Laws by Zenas BioPharma, Inc. in connection with certain allegedly false and misleading statements made in connection with Zenas BioPharma's September 2024 initial public offering (the "IPO").
Investors who purchased shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) have certain options and for certain investors are short and strict deadlines running. Deadline:…
Semtech Corporation (NASDAQ: SMTC) Investor Alert: Deadline in Lawsuit on April …
A deadline is coming up on April 22, 2025 in the lawsuit filed for certain investors of Semtech Corporation (NASDAQ: SMTC) over alleged securities laws violations by Semtech Corporation.
Investors who purchased shares of Semtech Corporation (NASDAQ: SMTC) have certain options and there are strict and short deadlines running. Deadline: April 22, 2025. NASDAQ: SMTC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Investigation announced for Long-Term Investors in shares of Five9, Inc. (NASDAQ …
An investigation was announced for current long-term investors in shares of Five9, Inc. (NASDAQ: FIVN) concerning potential breaches of fiduciary duties by certain directors of Five9, Inc.
Investors who are current long term investors in Five9, Inc. (NASDAQ: FIVN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: FIVN stocks…
More Releases for Maravai
Aptamers Market Industry Growth, Revenue, Opportunity and Industry Expansion Str …
Global Aptamers report from Global Insight Services is the single authoritative source of intelligence on Aptamers market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies.…
Immunofluorescence Assay Market to Witness Huge Growth by Key Players: Thermo Fi …
Global Immunofluorescence Assay Market 2021-2026, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Research Report of Immunofluorescence Assay Market @…
2022 Aptamers Market Report- by Technology, Opportunity Analysis and Industry Gr …
The Aptamers Market research report is represented with the assistance of diagrams which improves the comprehension of raw numbers. In addition, with the intensive contender investigation shrouded in Aptamers Market report, organizations can check or examine the contenders’ qualities and weak spots, which helps fabricate unrivaled business methodologies for their items.
Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=258340
Top Companies including in this Report-
Aptamer Group (UK), Raptamer Discovery Group (US),…
Aptamers Market worth $342 million by 2026 - Leading Key Players are Aptamer Gro …
According to the new market research report "Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026", published by MarketsandMarkets™, the global market was valued at an estimated USD 151 million in 2021 and is projected to reach USD 342 million by 2026, at a CAGR of 17.7% during…
Oligonucleotide Synthesis Market Growing Dynamically with Leading Top Key Player …
The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2028 from USD 6.3 billion in 2021, at a CAGR of +10% during the forecast period.
Market Research Inc latest study, titled “Global Oligonucleotide Synthesis Market” report to help readers accurately estimate the global market growth rate over the forecast period (2021-2028). Our research team has methodically performed quantitative and qualitative assessments of the Oligonucleotide Synthesis market dynamics,…
What is the Statistical data of top market players of Oligonucleotide Synthesis …
The Oligonucleotide Synthesis Market to reach 6.5 billion in 2021 and is growing at a CAGR of 17.6% over the forecast period. A thorough examination of market conditions, competitive patterns, product benefits and drawbacks, industry competitive dynamics (2018-2028), regional industrial layout features, macroeconomic policies, and trade policy has been covered. This industry's raw materials to downstream clients have all been thoroughly examined.
Key Players
The Oligonucleotide Synthesis market studied is a discreetly…
